- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02956668
tDCS Associated to Blindsight Rehabilitation for the Treatment of Homonymous Hemianopsia (TABRTHH)
Homonymous hemianopia is one of the most common symptoms following a neurologic damage and has many negative effects on functional abilities and daily activities.
There are two main kind of restorative rehabilitation of hemianopia: "border training", which involves exercising vision at the edge of the damaged visual field, and "blindsight training", which is based on exercising the unconscious perceptual functions in the mild of the blind hemifield.
In literature only border training effects were shown to be facilitated by transcranial direct current stimulation (tDCS).
The investigators treat two patients with blindsight rehabilitation associated to tDCS over parieto-occipital cortex. The two patients undergo a cycle of blindsight treatment associated to tDCS and a cycle of blindsight training alone in inverted order.
Aim of the study is to investigate if the anodic stimulation of perilesional areas enhance the improvement induced by blindsight rehabilitation treatment.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study design is a crossover AB BA. Treatment A consist in a cycle of blindsight training associated to tDCS, Treatment B consist in a a cycle of blindsight training alone.
During the blindsight training, the patient is asked to maintain central fixation and is exposed to visual stimuli in his blind hemifield. The patient task is detection and/or discrimination of stimuli.
During each session the patient is subjected to around 700 different stimuli variously associated in space and/or time.
One out of two blindsight training cycles is associated to tDCS treatment. Anodal tDCS is applied using a battery-driven constant current stimulator, and a pair of surface saline-soaked sponge electrodes (5 x 5 cm). Current intensity is of 2 mA (Fade-in/-out= 10 sec), for a total duration of 30 min. The stimulation start at the beginning of the rehabilitation session, and continue for 30 min, during treatment.
Anode is placed over the parieto-occipital cortex. The cathode is placed in the contralateral supraorbital position.
To assess the actual improvement patients performed:
- Clinical-instrumental assessment: Threshold visual field Humphrey SITA-standard 30-2 program is used to measure the visual perception within the central 30 degrees.
- Peripheral visual field test Schofield Vienna PP-R test is used to measure the visual perception up to 180 degrees. A double task in central vision was performed in order to verify test reliability.
- Functional visual field assessment: Test for Attention Performance (TAP - v. 2.3) visual field 92 stimuli subtest (26) is performed.
- Ecological assessment: during initial and final interview an ICF profile of the subject is edited. The profile includes mainly the Activity and Participation categories of ICF.
All these investigations is performed before the treatment and after each cycle
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
CB
-
Carate Brianza, CB, Italy, 20841
- Polo universitario presso I.C. Zucchi
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- The subject is able to give his informed consent
- Stroke
- Hemianopsia brain damage documented by means of TAC or RMN
- Hemianopsia diagnosed by means automated visual field and Neurological Evaluation
- Time from lesion at least six months
- normal or corrected-to-normal visual acuity
Exclusion Criteria:
- Presence of Ophthalmologic neuropsychologic or psychiatric pathology
- Global cognitive deficit,
- Presence of other neurological pathology
- Presence of cardiac peacemaker
- Presence metallic or electronic items in the head or in the body
- Story/familiarity of epilepsy, taking medications that can induce epileptic crisis
- Severe heart disease
- History of high alcohol consumption
- Pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Blindsight training associated to tDCS
During the blindsight training (one-hour time), the patient is asked to maintain central fixation and is exposed to visual stimuli in his blind hemifield. The patient task is detection and/or discrimination of stimuli. During each session the patient is subjected to around 700 different stimuli variously associated in space and/or time. tDCS stimulation start at the beginning of the rehabilitation session, and continue for 30 min, during treatment. Anode is placed over the parieto-occipital cortex. The cathode is placed in the contralateral supraorbital position. |
The patient undergo visual rehabilitation while his brain is electrically stimulated with tDCS.
|
Active Comparator: Blindsight training alone
During the blindsight training (one-hour time), the patient is asked to maintain central fixation and is exposed to visual stimuli in his blind hemifield. The patient task is detection and/or discrimination of stimuli. During each session the patient is subjected to around 700 different stimuli variously associated in space and/or time. |
The patient undergo visual rehabilitation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in Humphrey visual field 30.2 SITA standard test
Time Frame: 10 weeks and 20 weeks
|
10 weeks and 20 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in Battery for Attentional Performance (TAP) subtest: Visual Field
Time Frame: 10 weeks and 20 weeks
|
10 weeks and 20 weeks
|
International Classification of Functioning (ICF)
Time Frame: 20 weeks
|
20 weeks
|
Change in Schuhfried Vienna Test Peripheral Perception (PP-R)
Time Frame: 10 weeks and 20 weeks
|
10 weeks and 20 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Barbara M Matteo, Università degli studi di Milano - Bicocca
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 264-BSTDCS
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hemianopsia
-
Nunaps IncCompletedVisual Fields Hemianopsia | Hemianopsia, HomonymousKorea, Republic of
-
Nunaps IncActive, not recruitingVisual Fields Hemianopsia | Hemianopsia, HomonymousKorea, Republic of
-
Wake Forest University Health SciencesCompletedHemianopia, Homonymous | Hemianopsia, HomonymousUnited States
-
NovaVision, Inc.SuspendedHemianopsia, HomonymousUnited States
-
Istituto Auxologico ItalianoCompletedStroke | Hemianopsia, HomonymousItaly
-
University of RochesterNational Institutes of Health (NIH)RecruitingStroke, Ischemic | Stroke Hemorrhagic | Visual Field Defect, Peripheral | Hemianopsia | Hemianopia | Quadrantanopia | Homonymous Hemianopia | Occipital Lobe Infarct | Visual Fields Hemianopsia | Vision Loss Partial | Peripheral Visual Field Defect of Both Eyes | Peripheral Visual Field Defect | Homonymous Hemianopsia and other conditionsUnited States
-
Ain Shams UniversityCompletedStroke, Ischemic | Stroke Hemorrhagic | Visual Fields HemianopsiaEgypt
-
Beth Israel Deaconess Medical CenterRecruitingStroke | Visual Impairment | Visual Field Defect, Peripheral | Visual Field Defect Homonymous Bilateral | Hemianopsia | Quadrantanopia | Cortical Blindness | Occipital Lobe Infarct | Visual Fields HemianopsiaUnited States
-
Alexandra BowersNational Eye Institute (NEI); Chadwick Optical Inc.CompletedHomonymous HemianopiaUnited States, United Kingdom
-
Institute of Child HealthEnrolling by invitation
Clinical Trials on Blindsight Training associated to tDCS
-
Rubens da SilvaLondrina Santa casa HospitalNot yet recruitingChronic Pain | Musculoskeletal Disorders | Functional LimitationsBrazil
-
Federal University of ParaíbaUnknown
-
Universidade Federal de Sao CarlosFundação de Amparo à Pesquisa do Estado de São Paulo; Conselho Nacional de...CompletedStroke | HemiparesisBrazil
-
Nantes University HospitalActive, not recruiting
-
King's College LondonNot yet recruitingAdults With Overweight and Obesity
-
VA Greater Los Angeles Healthcare SystemCompletedSchizophreniaUnited States
-
Universidade Federal de PernambucoUnknownDiabetes Mellitus, Type 2Brazil
-
IRCCS Centro San Giovanni di Dio FatebenefratelliAzienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaActive, not recruitingPrimary Progressive AphasiaItaly
-
Universitätsklinikum Hamburg-EppendorfActive, not recruitingStrokeGermany, Austria, Italy
-
The Hong Kong Polytechnic UniversityThe University of Hong Kong; University of Magdeburg; University of WaterlooRecruiting